Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Mingting Chen"'
Autor:
Wen Li, Jia Wang, Wenzhong Huang, Yu Yan, Yanming Liu, Qi Zhao, Mingting Chen, Liping Yang, Yuming Guo, Wei Ma
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Under a changing climate, the joint effects of temperature and relative humidity on tuberculosis (TB) are poorly understood. To address this research gap, we conducted a time-series study to explore the joint effects of temperatur
Externí odkaz:
https://doaj.org/article/98c99f4ac6e94149a992b76403286f1c
Autor:
Guoqin Zhang, Yanming Yu, Wenqian Zhang, Jian Shang, Shengyu Chen, Xuewen Pang, John E. Oeltmann, Patrick K. Moonan, Mingting Chen, Fan Zhang
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe COVID-19 pandemic has disrupted the diagnosis, treatment, and care for tuberculosis (TB). Delays in seeking TB care may result in increased community transmission and unfavorable treatment outcomes. We sought to understand the influence
Externí odkaz:
https://doaj.org/article/f60ceb415d3447168307d0d270aa698c
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Bacteriological confirmation (BC) proportion among notified pulmonary TB patients in China is among the lowest in the world. This study was to understand the yield of BC using different testing strategies and patient-level factors
Externí odkaz:
https://doaj.org/article/1c28334f9b18400687e160ea54ebb37c
Autor:
Lixia Wang, Renzhong Li, Caihong Xu, Hui Zhang, Yunzhou Ruan, Mingting Chen, Dongmei Wang, Emilio Dirlikov, Xin Du, Jin Zhao, Yanlin Zhao, ShengFen Wang, Yuhong Liu, Liang Li, Dennis Falzon, Yanni Sun, Yu Wang, Bernhard Schwartländer, Fabio Scano
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0177536 (2017)
China has the world's second largest burden of multidrug-resistant tuberculosis (MDR-TB; resistance to at least isoniazid and rifampicin), with an estimated 57,000 cases (range, 48,000-67,000) among notified pulmonary TB patients in 2015. During Octo
Externí odkaz:
https://doaj.org/article/b2100f187a094c5389cb9b01a1258b06
Autor:
Renzhong Li, MS, Yunzhou Ruan, PhD, Qiang Sun, PhD, Xiexiu Wang, MS, Mingting Chen, MS, Hui Zhang, PhD, Yanlin Zhao, PhD, Jin Zhao, MS, Cheng Chen, MS, Caihong Xu, MS, Wei Su, MS, Yu Pang, PhD, Jun Cheng, MS, Junying Chi, MS, Qian Wang, MS, Yunting Fu, MS, Shitong Huan, MS, Lixia Wang, MS, Dr. Yu Wang, PhD, Daniel P Chin, MD
Publikováno v:
The Lancet Global Health, Vol 3, Iss 4, Pp e217-e228 (2015)
Background: China has a quarter of all patients with multidrug-resistant tuberculosis (MDRTB) worldwide, but less than 5% are in quality treatment programmes. In a before-and-after study we aimed to assess the effect of a comprehensive programme to p
Externí odkaz:
https://doaj.org/article/c04113b8ccd24002a5a0bea7dde13d49
Autor:
Tao Li, Fei Huang, Ni Wang, Hui Zhang, Lixia Wang, Miaomiao Sun, You Li, Mingting Chen, Shitong Huan, Xin Du, Yanlin Zhao
Publikováno v:
China CDC Weekly
What is already known about this topic? China’s national health information system provides important support and means for deepening the country’s medical and health reform, for improving relevant delivery services, for enhancing the level of sc
Publikováno v:
China CDC Weekly
What is already known about this topic? Tuberculosis (TB) notification data and the underreporting rate are major sources used in estimating TB incidence. China’s TB Information Management System (TBIMS) was launched in 2005 but has not yet been ev
Publikováno v:
China CDC Weekly
Autor:
Hui Zhang, Caihong Xu, Jianjun Liu, Tao Li, Xiaoqiu Liu, Dongmei Hu, Yanlin Zhao, Mingting Chen, Xue Li
Publikováno v:
China CDC Weekly
Tuberculosis (TB) is a global public health problem, especially in China. China has the third largest TB burden in the world with nearly 0.9 million new TB cases emerging annually. Despite impressive achievements, China still faces many challenges in
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-9 (2020)
Background Bacteriological confirmation rate among notified pulmonary TB patients in China is among the lowest in the world. This study was to understand the yield of bacteriological confirmation using different testing strategies and patient-level f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e73b1846343e7e18294ae473963307
https://doi.org/10.21203/rs.3.rs-32410/v1
https://doi.org/10.21203/rs.3.rs-32410/v1